OBJECTIVE: To evaluate the clinical impact of a comprehensive medication management (CMM) service in a Brazilian primary health-care setting. METHODS: A quasi-experimental study has been carried out between July 2014 and November 2016 with patients who received the service in the primary care setting of a Brazilian city (n = 1057). Factors associated with drug therapy problems (DTP) detection in the initial assessment were evaluated by performing univariate and multivariate analyzes. To evaluate the impact of the CMM service, a linear regression model was constructed from the difference between the initial and final values of the clinical and laboratory parameters adjusted by multiple variables. RESULTS: A total of 1642 DTPs was identified, the most prevalent one being "nonadherence" (31.9%) and the "need for additional drug therapy" (22.9%). The use of 5 or more medications and the presence of 3 or more diseases were positively associated with the identification of 3 or more DTPs during the initial assessment. Even after multiple adjustments, a statistically significant reduction has been observed in the values of glycated hemoglobin, systolic blood pressure, low-density cholesterol, and total cholesterol. CONCLUSION: The CMM service contributed to the resolution of DTP and showed positive clinical impact in primary health care in the studied setting.
OBJECTIVE: To evaluate the clinical impact of a comprehensive medication management (CMM) service in a Brazilian primary health-care setting. METHODS: A quasi-experimental study has been carried out between July 2014 and November 2016 with patients who received the service in the primary care setting of a Brazilian city (n = 1057). Factors associated with drug therapy problems (DTP) detection in the initial assessment were evaluated by performing univariate and multivariate analyzes. To evaluate the impact of the CMM service, a linear regression model was constructed from the difference between the initial and final values of the clinical and laboratory parameters adjusted by multiple variables. RESULTS: A total of 1642 DTPs was identified, the most prevalent one being "nonadherence" (31.9%) and the "need for additional drug therapy" (22.9%). The use of 5 or more medications and the presence of 3 or more diseases were positively associated with the identification of 3 or more DTPs during the initial assessment. Even after multiple adjustments, a statistically significant reduction has been observed in the values of glycated hemoglobin, systolic blood pressure, low-density cholesterol, and total cholesterol. CONCLUSION: The CMM service contributed to the resolution of DTP and showed positive clinical impact in primary health care in the studied setting.
Entities:
Keywords:
medication therapy management; outcome assessment; pharmaceutical care; pharmaceutical services; primary health care
Authors: Christina M Polomoff; Angela Bermudez-Millan; Thomas Buckley; Orfeu M Buxton; Richard Feinn; Sengly Kong; Theanvy Kuoch; Mackenzie Lim; Mary Scully; Julie Wagner Journal: J Am Pharm Assoc (2003) Date: 2021-10-30
Authors: Iva Mucalo; Andrea Brajković; Marija Strgačić; Djenane Ramalho-de-Oliveira; Elizabeta Ribarić; Ana Bobinac Journal: Healthcare (Basel) Date: 2022-04-13
Authors: Joseph P Jarvis; Arul Prakasam Peter; Murray Keogh; Vince Baldasare; Gina M Beanland; Zachary T Wilkerson; Steven Kradel; Jeffrey A Shaman Journal: J Pers Med Date: 2022-03-08
Authors: Andrea Brajković; Lorena Bosnar; Mariana Martins Gonzaga do Nascimento; Ingrid Prkačin; Antonija Balenović; Djenane Ramalho de Oliveira; Iva Mucalo Journal: Int J Environ Res Public Health Date: 2022-02-27 Impact factor: 3.390